Enhanced Recovery After Cardiac Surgery : A Propensity-Matched Analysis
Copyright © 2021 Elsevier Inc. All rights reserved..
Enhanced Recovery After Surgery (ERAS) pathways have improved clinical outcomes, cost-effectiveness, and patient satisfaction across multiple non-cardiac surgical specialties. Since the adaptation of ERAS in cardiac surgery is rapidly increasing yet still evolving, herein, we demonstrate early results of our implementation of ERAS cardiac guidelines. We retrospectively reviewed all patients who were managed with our institutional ERAS Cardiac Surgery guidelines between 5/2018 and 6/2019(N = 102). Postoperative primary outcomes (total ventilation times(hours), intensive-care unit(ICU) stay, and postoperative hospital length of stay (LOS)) were compared to 1:1 propensity matched controls from the pre ERAS era between January 2017 and March 2019. A total of 76 propensity-matched pairs were identified. Compared to the matched controls, ERAS patients had significantly shorter median ventilation times(3.5 vs. 5.3 hours, p = .01), ICU stays(median 28 vs 48 hours, p=.005) and postoperative hospital LOS (median 5 vs. 6 days, p = .03). There were no operative mortalities and no significant differences in 30-day readmission rates. There were also no significant differences in post-operative stroke, acute kidney injury, atrial fibrillation, and reoperation rates for bleeding. Two-year survival was also not statistically different between the two cohorts (p = .22). Our initial experience with implementation of ERAS protocols in cardiac surgery appear to demonstrate that these protocols are associated with shorter ventilation times, ICU stay, and hospital LOS without compromising patient outcomes. While these results are promising yet preliminary, further studies are warranted to demonstrate whether ERAS algorithms in cardiac surgery can consistently expedite postoperative recovery and improve outcomes.
| Errataetall: |
CommentIn: Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):595-596. - PMID 34139349 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Seminars in thoracic and cardiovascular surgery - 34(2022), 2 vom: 01., Seite 585-594 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yazdchi, Farhang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.06.2022 Date Revised 09.06.2022 published: Print-Electronic CommentIn: Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):595-596. - PMID 34139349 Citation Status MEDLINE |
|---|
| doi: |
10.1053/j.semtcvs.2021.05.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326380647 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326380647 | ||
| 003 | DE-627 | ||
| 005 | 20231225194452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.semtcvs.2021.05.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1087.xml |
| 035 | |a (DE-627)NLM326380647 | ||
| 035 | |a (NLM)34089824 | ||
| 035 | |a (PII)S1043-0679(21)00261-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yazdchi, Farhang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhanced Recovery After Cardiac Surgery |b A Propensity-Matched Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2022 | ||
| 500 | |a Date Revised 09.06.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):595-596. - PMID 34139349 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a Enhanced Recovery After Surgery (ERAS) pathways have improved clinical outcomes, cost-effectiveness, and patient satisfaction across multiple non-cardiac surgical specialties. Since the adaptation of ERAS in cardiac surgery is rapidly increasing yet still evolving, herein, we demonstrate early results of our implementation of ERAS cardiac guidelines. We retrospectively reviewed all patients who were managed with our institutional ERAS Cardiac Surgery guidelines between 5/2018 and 6/2019(N = 102). Postoperative primary outcomes (total ventilation times(hours), intensive-care unit(ICU) stay, and postoperative hospital length of stay (LOS)) were compared to 1:1 propensity matched controls from the pre ERAS era between January 2017 and March 2019. A total of 76 propensity-matched pairs were identified. Compared to the matched controls, ERAS patients had significantly shorter median ventilation times(3.5 vs. 5.3 hours, p = .01), ICU stays(median 28 vs 48 hours, p=.005) and postoperative hospital LOS (median 5 vs. 6 days, p = .03). There were no operative mortalities and no significant differences in 30-day readmission rates. There were also no significant differences in post-operative stroke, acute kidney injury, atrial fibrillation, and reoperation rates for bleeding. Two-year survival was also not statistically different between the two cohorts (p = .22). Our initial experience with implementation of ERAS protocols in cardiac surgery appear to demonstrate that these protocols are associated with shorter ventilation times, ICU stay, and hospital LOS without compromising patient outcomes. While these results are promising yet preliminary, further studies are warranted to demonstrate whether ERAS algorithms in cardiac surgery can consistently expedite postoperative recovery and improve outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cardiac Surgery | |
| 650 | 4 | |a Enhanced Recovery | |
| 700 | 1 | |a Hirji, Sameer |e verfasserin |4 aut | |
| 700 | 1 | |a Harloff, Morgan |e verfasserin |4 aut | |
| 700 | 1 | |a McGurk, Siobhan |e verfasserin |4 aut | |
| 700 | 1 | |a Morth, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Zammert, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Shook, Douglas |e verfasserin |4 aut | |
| 700 | 1 | |a Varelmann, Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Shekar, Prem |e verfasserin |4 aut | |
| 700 | 1 | |a Kaneko, Tsuyoshi |e verfasserin |4 aut | |
| 700 | 0 | |a ERAS Working Group |e verfasserin |4 aut | |
| 700 | 1 | |a Bedeir, Kareem |e verfasserin |4 aut | |
| 700 | 1 | |a Madou, Isidore Dinga |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Percy, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Kiehm, Spencer |e verfasserin |4 aut | |
| 700 | 1 | |a Woo, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Bentain-Melanson, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Swanson, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Rawn, James |e verfasserin |4 aut | |
| 700 | 1 | |a Rinewalt, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Mallidi, Hari Reddy |e verfasserin |4 aut | |
| 700 | 1 | |a Sabe, Ashraf |e verfasserin |4 aut | |
| 700 | 1 | |a Aranki, Sary |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in thoracic and cardiovascular surgery |d 1996 |g 34(2022), 2 vom: 01., Seite 585-594 |w (DE-627)NLM012939013 |x 1532-9488 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2022 |g number:2 |g day:01 |g pages:585-594 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1053/j.semtcvs.2021.05.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2022 |e 2 |b 01 |h 585-594 | ||